Journal
CLINICAL INFECTIOUS DISEASES
Volume 73, Issue 11, Pages 1965-1972Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciab570
Keywords
effectiveness; intravenous artesunate; safety; severe malaria; United States
Categories
Ask authors/readers for more resources
This study investigated the safety and effectiveness of IVAS for the treatment of severe malaria in the United States. The results showed that IVAS is a safe and effective drug, and timely administration can be lifesaving.
Background. Severe malaria can be deadly and requires treatment with intravenous artesunate (IVAS). The Centers for Disease Control and Prevention provided IVAS starting 1 April 2019 for all patients with severe malaria in the United States. This study describes the safety and effectiveness of IVAS in these patients. Methods. Patients meeting criteria for severe malaria April 2019-December 2020 who received IVAS were included. Demographic, clinical, laboratory, adverse event, and outcome information were collected. Clinical presentation, time to reach 1% and 0% parasitemia, adverse events, and death were described using proportions, medians, interquartile range (IQR), and tests of significance for differences in proportions. Results. Of 280 patients included, the majority were male (61.4%), Black (75.0%), with a median age of 35 years (IQR: 15.8-53.9). Most had Plasmodium falciparum (83.6%) with median parasitemia of 8.0% (IQR: 4.6-13.2). Of 170 patients with information, 159 (93.5%) reached <= 1% parasitemia by the third IVAS dose with a median time of 17.6 hours (IQR: 10.8-28.8), and 0% parasitemia in a median of 37.2 hours (IQR 27.2-55.2). Patients with parasite densities >10% and those requiring adjunct therapy had significantly higher parasite clearance times. Adverse events associated with IVAS were reported in 4.8% (n = 13 of 271). Eight patients had post-artesunate delayed hemolysis that resolved. There were 5 (1.8%) deaths, all attributable to severe malaria. Conclusions. IVAS is a safe and effective drug for the treatment of severe malaria in the United States; timely administration can be lifesaving.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available